Results 81 to 90 of about 192 (165)

Risk Factors Related with Doxorubicin-Induced Cardiotoxicity

open access: yes, 2018
The aim of this thesis was to evaluate risk factors related with cardiotoxicity for patients who were treated with doxorubicin. Objectives: to evaluate risk factors (age, family history of cardiovascular disease, smoking) related with doxorubicin-induced
Ambrazevičiūtė, Gretė
core  

Efectes moduladors de les hormones sexuals femenines sobre el sistema cardiovascular en la diabesitat

open access: yes, 2021
[cat] El paper protector dels estrògens front l’obesitat, la diabetis i les seves complicacions a nivell cardiovascular és objecte d’estudi. Alguns estudis han posat de manifest que les rates femella presenten una major capacitat de resistència al ...
González Vicens, Agustín
core  

The nature of the medical treatment of chronic heart failure patients

open access: yes, 2017
Hroniska sirds mazspēja ir viena no pasaulē biežākajām kardiovaskulārajām saslimšanām. Hroniskas sirds mazspējas ārstēšanai paredzētie medikamenti tiek iedalīti 9 grupās - beta adrenoblokatori (BAB), angiotenzīnu konvertējošā enzīma inhibitori (AKE-I ...
Eglīte, Laura
core  

Preparation of liposomes with an encapsulat ed cardioprotector, study of physicochemical properties, release kinetics and biodistribution in vivo

open access: yesTranslational Medicine
Background. Liposomal drug delivery systems are increasingly used in clinical practice due to their ability to improve the pharmacokinetic profile and reduce the systemic toxicity of drugs. Quinacrine is a promising drug with proven cardioprotective and antiviral activity, however, its use is limited by side effects. The development of a liposomal form
A. I. Nikiforov   +4 more
openaire   +1 more source

Moringa oleifera Leaves Extract Ameliorates Doxorubicin-Induced Cardiotoxicity via Its Mitochondrial Biogenesis Modulatory Activity in Rats. [PDF]

open access: yesJ Exp Pharmacol, 2023
Patintingan CG   +6 more
europepmc   +1 more source

Editorial: Mesenchymal Stromal Cell Therapy for Regenerative Medicine. [PDF]

open access: yesFront Cell Neurosci, 2022
Capilla-González V   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy